US Patent Issued to Schedule 1 Therapeutics on Aug. 18 for "Compositions comprising cannabinoids and methods of use thereof" (Illinois Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,631, issued on Aug. 18, was assigned to Schedule 1 Therapeutics Inc. (Chicago).

"Compositions comprising cannabinoids and methods of use thereof" was invented by George D. Pappas (Oak Park, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is related to the use of compositions and their use in reducing pain."

The patent was filed on Feb. 10, 2020, under Application No. 17/429,259.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12708631&OS=12708631&RS=12708...